Item 5. Market for Registrant’s Common Equity
Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters, and Issuer Purchases of Equity Securities.
(a) Market Information
Our Units, Public Shares and Public Warrants are
each traded on the Global Market tier of Nasdaq under the symbols “ PCAPU”, “PCAP”
and “PCAPW” , respectively. Our Units commenced public trading on May 21, 2025 ,
and our Public Shares and Public Warrants commenced separate public trading on July 11, 2025.
(b) Holders
On March 12, 2026, there was one (1) holder of
record of our Units, one (1) holder of record of our Class A ordinary shares, one (1) holder of record of our Class B ordinary shares,
and one (1) holders of record of our Warrants.
(c) Dividends
We have not paid any cash dividends on our Ordinary
Shares to date and do not intend to pay cash dividends prior to the completion of our initial Business Combination. The payment of cash
dividends following completion of our initial Business Combination will be dependent upon our revenues and earnings, if any, capital requirements
and general financial condition subsequent to completion of our initial Business Combination. The payment of any cash dividends subsequent
to our initial Business Combination will be within the discretion of our Board of Directors at such time. In addition, our Board of Directors
is not currently contemplating and does not anticipate declaring any share dividends in the foreseeable future. Further, if we incur any
indebtedness in connection with our initial Business Combination, our ability to declare dividends following completion of our initial
Business Combination may be limited by restrictive covenants we may agree to in connection therewith.
(d) Securities Authorized for
Issuance Under Equity Compensation Plans
None.
(e) Performance Graph
As a smaller reporting company, we are not required
to provide the information required by Regulation S-K Item 201(e).
(f) Recent Sales of Unregistered
Securities
Simultaneously with the closing of the Initial
Public Offering, the Company consummated the sale of 430,000 Private Placement Units at a price of $10.00 per Private Placement Unit,
in a private placement to the Sponsor, generating gross proceeds to the Company of $4,300,000. The Private Placement Units (and underlying
securities) are identical to the Units sold in the Initial Public Offering, except as otherwise disclosed in our IPO Registration Statement.
No underwriting discounts or commissions were paid with respect to such sale. The issuance of the Private Placement Units was made pursuant
to the exemption from registration contained in Section 4(a)(2) of the Securities Act of 1933, as amended.
(g)
Use of Proceeds from the Initial Public Offering
On May 22, 2025, we consummated our Initial Public
Offering of 25,000,000 Units, which includes the partial exercise by the Underwriters of their overallotment option in the amount of 3,000,000
Units, at $10.00 per Unit, generating gross proceeds of $250,000,000. Each Unit consists of one Class A ordinary share and one-third
of one redeemable warrant, with each whole Warrant entitling the holder to purchase one Class A ordinary share at a price of $11.50 per
share, subject to adjustment.
26
The Units were sold at a price of $10.00 per Unit,
generating gross proceeds to us of $250,000,000. Simultaneously with the consummation of our Initial Public Offering and pursuant to the
Private Placement Units Purchase Agreement, we completed the sale of 430,000 Private Placement Units at a price of $10.00 per Private
Placement Unit, in a private placement to our Sponsor, generating gross proceeds of $4,300,000. Each Private Placement Unit consists of
one Class A ordinary share and one-third of one redeemable warrant. Following the closing of our Initial Public Offering on May 22, 2025,
a total of $250,000,000 (which amount includes $11,250,000 of the deferred underwriting fee) was placed in a U.S.-based Trust Account
maintained by Odyssey Transfer and Trust Company, acting as trustee. The proceeds held in the Trust Account may be invested by the trustee
only in U.S. government securities with a maturity of 185 days or less or in money market funds investing solely in U.S. government treasury
obligations and meeting certain conditions under Rule 2a-7 under the Investment Company Act. The Company may, at any time (based on Management
Team’s ongoing assessment of all factors related to the potential status under the Investment Company Act), instruct the trustee
to liquidate the investments held in the Trust Account and instead to hold the funds in the Trust Account in cash or in an interest bearing
demand deposit account at a bank. To mitigate the risk that we might be deemed to be an investment company for purposes of the Investment
Company Act, which risk increases the longer that we hold investments in the Trust Account, we may, at any time (based on the Management
Team’s ongoing assessment of all factors related to the potential status under the Investment Company Act), instruct the trustee
to liquidate the investments held in the Trust Account and instead to hold the funds in the Trust Account in cash or in an interest-bearing
demand deposit account at a bank.
Transaction costs amounted to $14,026,609, consisting
of $2,200,000 of cash underwriting fee, $11,250,000 of deferred underwriting fee, and $576,609 of other offering costs.
The remaining proceeds from the Initial Public
Offering and the Private Placement are held outside the Trust Account. Such funds are being used primarily to enable us to identify a
target and to negotiate and consummate our initial Business Combination.
There has been no material change in the planned
use of the proceeds from our Initial Public Offering and the Private Placement as described in the IPO Registration Statement. The specific
investments in our Trust Account may change from time to time
(h) Purchases of Equity Securities
by the Issuer and Affiliated Purchasers
There were
no such repurchases of our equity securities by us or an affiliate during the fourth quarter of the fiscal year covered by the Report.
Item 6. [Reserved]